Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See
full details
.
I Agree
×
Join today and have your say! It’s FREE!
Join Now
Sign In
Become a member today, It's free!
We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.
Join Today
or
Sign in with existing account
Privacy Policy
|
Disclaimer
Sign In
Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Remember me
Forgot Password?
Sign In
or
Sign Up
Privacy Policy
|
Disclaimer
Please Try Again
{{ error }}
Send my password
Submit
Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.
Become a member today, It's free!
We will not release or resell your information to third parties without your permission.
Linking with Facebook:
Stockhouse membership requires an email address which must be shared by Facebook.
By default, joining or signing in using your Facebook account will work and the email address will be shared by Facebook automatically.
If you change your Facebook permissions to restrict Stockhouse from receiving your email while joining or signing in to Stockhouse then it will fail.
Please do not modify the permission settings during sign-in.
Sign in with Facebook
Return to Signup Options
Home
Community
Bullboards
Blogs
Groups
Messages
Markets
Stocks
TSX
TSXV
CSE
NASDAQ
NYSE
NYSE American
Cryptocurrency
Currencies
Market Movers
News
Featured News
Trending News
Canadian Press Releases
US Press Releases
Video
Editorial
Thematic Insights
Independent Reports
Interviews
Buzz on the Bullboards
Portfolio
Watchlist
Portfolio
Showcase Companies
DealRoom
Quote
|
Bullboard
|
News
|
Opinion
|
Profile
|
Peers
|
Filings
|
Financials
|
Price History
|
Ratios
|
Insiders
Bullboard - Stock Discussion Forum
Baudax Bio Inc (EM)
BXRXQ
Healthcare
Biotechnology
Baudax Bio, Inc., a pharmaceutical company, develops and commercializes products for hospital and other acute care related settings. The company offers ANJESO (meloxicam) injection for the management of moderate to severe pain, alone or in combination with other non-NSAID analgesics. It also develops BX1000, an intermediate-acting neuromuscular blocking agent (NMB) that is in phase II clinical...
trial; BX2000, an ultra- short acting NMB, which is in phase I clinical trial, as well as a proprietary blockade reversal agent; and BX3000, a NMB reversal agent that is in preclinical studies. Baudax Bio, Inc. was incorporated in 2019 and is based in Malvern, Pennsylvania. On February 22, 2024, Baudax Bio, Inc. filed a voluntary petition for reorganization under Chapter 11 in the U.S. Bankruptcy Court for the Eastern District of Pennsylvania.
see more
Join the community and start posting on the bullboards today. It's free.
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
Add To Watchlist
Create a portfolio watchlist today. It's free.
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
Bullboard (EXPM:BXRXQ)
New Post
View:
Posts & Comments
Threaded Posts
Prev
1
2
3
4
5
6
7
Next
(1069)
•••
Iseneschal
X
Post by
Iseneschal
on Jun 30, 2023 11:05am
BXRX....Halted again on the way down
In PB mode now.....me no position Cheers and GLTA
(1069)
•••
Iseneschal
X
Post by
Iseneschal
on Jun 30, 2023 10:58am
BXRX.....3rd scalp..... I'm done now
going camping ....Cheers !
Mobix Labs Secures Significant U.S. Navy Tomahawk Missile Component Order
posted Mar 05, 2026 9:00am by
Mobix Labs Inc
-
|
This order reflects active, ongoing production demand within an operational U.S. Navy weapons platform. The company’s tech is integrated into the Tomahawk program, and as production volumes increase, demand for our proven high-reliability filtering component increases ...read more
(1069)
•••
Iseneschal
X
Post by
Iseneschal
on Jun 30, 2023 10:53am
BXRX....Volume & price action..Love it
Here i go pumping..... But ...wouldn't surprise me to see this get to the DTL trend line..... somewhere around ~ $2
(1069)
•••
Iseneschal
X
Post by
Iseneschal
on Jun 30, 2023 10:47am
BXRX..... Halted again....on the rising swell upward
This has a history of big intra-day swings Trade accordingly ; )
(1069)
•••
Iseneschal
X
Post by
Iseneschal
on Jun 30, 2023 10:44am
BXRX.....Ride the wave ; )
What a rip
(1069)
•••
Iseneschal
X
Post by
Iseneschal
on Jun 30, 2023 10:30am
BXRX ....Now did you just see that !!!!!!!!!!!!!
WTF
(1069)
•••
Iseneschal
X
Post by
Iseneschal
on Jun 30, 2023 10:28am
BXRX.....2nd scalp ; )
More profit .... Cheers !
(1069)
•••
Iseneschal
X
Post by
Iseneschal
on Jun 30, 2023 10:27am
BXRX ....all the TA's see that big gap
good luck
(1069)
•••
Iseneschal
X
Post by
Iseneschal
on Jun 30, 2023 10:22am
BXRX .....NIce scalp!
Never did get down to 60.....bot some at 65...........sold at 78 Thanks for the great profit !!!!
(1069)
•••
Iseneschal
X
Post by
Iseneschal
on Jun 30, 2023 9:38am
BXRX.... LMFAO....Has to hold 60 pesos or
it's done What a game
(1069)
•••
Iseneschal
X
Post by
Iseneschal
on Jun 30, 2023 9:28am
BXRX....what it going to be
Instant Retail face rip.....or rally?
(0)
•••
PressRelease
X
Post by
PressRelease
on May 12, 2023 8:32am
New Press Release - Baudax Bio Reports First Quarter Financial Results and Provides Business Update
Announced Positive Top-Line Final Results from Phase 2 Randomized Clinical Trial of BX1000 Hosted Key Opinion Leader Webinar to Highlight Potential of BX1000 and Neuromuscular Blocking Agent Portfolio Secured $4 Million in Gross Proceeds from Public Offering in MayMALVERN, Pa., May 12, 2023...
read article.
(0)
•••
PressRelease
X
Post by
PressRelease
on May 03, 2023 4:05pm
New Press Release - Baudax Bio to Present at the Sidoti Virtual Investor Conference
MALVERN, Pa., May 03, 2023 (GLOBE NEWSWIRE) -- Baudax Bio, Inc. (Nasdaq:BXRX) (the “Company”), a pharmaceutical company focused on innovative products for hospital and related settings, today announced that Gerri Henwood, the Company’s President and Chief Executive Officer, will present and host...
read article.
(0)
•••
PressRelease
X
Post by
PressRelease
on May 01, 2023 5:43pm
New Press Release - Baudax Bio Announces Closing of $4 Million Public Offering
MALVERN, Pa., May 01, 2023 (GLOBE NEWSWIRE) -- Baudax Bio, Inc. (the “Company” or “Baudax Bio”) (NASDAQ: BXRX), a pharmaceutical company focused on innovative products for hospital and related settings, today announced the closing of its previously announced public offering of an aggregate of 3...
read article.
(1069)
•••
Iseneschal
X
Post by
Iseneschal
on Apr 27, 2023 9:04am
BXRX....see my previous post
Down a ton in the Pre-Market open.....No kidding.....the timing of the events are very suspect. Maddapakkas !!!! No position
Prev
1
2
3
4
5
6
7
Next
Thank You
Your Report has been submitted.
Report Abusive Content
×
Close
Sign up to get access
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
Market Update
{{currentVideo.title}}
{{currentVideo.relativeTime}}
{{previousButtonTitle}}
{{nextButtonTitle}}
A daily snapshot of everything
from market open to close.
{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}
{{currentVideo.intervieweeTitle}}
{{currentVideo.headline}}
{{currentVideo.link1Text}}
{{currentVideo.link2Text}}
< Previous
{{moreVideoText}}
Next >
Featured News Links
NU E Power Strengthens Senior Leadership to Support Delivery of Rapidly Expanding Global Energy Infrastructure Portfolio
Tungsten has quietly become one of the most strategic metals on the planet
TomaGold Initiates Major Phase 2 Program at Berrigan Mine to Test Berrigan Deep Potential
Pelangio Exploration Commissions a Deep-Penetrating CSEM Survey for the Obuasi and Manfo Projects, Ghana
Cielo Closes Private Placement Previously Announced in Connection with Strategic Asset Acquisition
Allied Critical Metals Delivers Robust Initial PEA at the Borralha Project
Sorrento Resources Identifies Several High-Grade Soil Gold Anomalies up to 525m by 450m in Size, Newfoundland
Spanish Mountain Receives Positive Particle Ore Sorting Results Highlighting Production Upside
Podcasts